(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. (A) Schematic diagram of the Nfatc1 promoter/enhancer reporter
constructs. (B) Transient transgenic embryos following X-gal staining
documents that the 6.2-kb NheI-XhoI P1 promoter-reporter
(NX-lacZ) does not produce endocardial gene expression at E11.5. However, the
BB-HSP-lacZ enhancer-reporter, containing 4.1 kb
BssHII-BssHII fragment of the P2 (intron 1) regulatory
region, linked to the HSP68 minimal promoter, is able to drive expression
specifically in the endocardial lumen of the atrioventricular canal (AVC) and
in the conal (c) and truncal (t) regions of the developing outflow tract. No
expression is detected in the atrium (a) or ventricle (v) or in the
extracardiac vasculature. (C) Table summaries this group of transgenic
experiments. TG, transgenic embryos; ECS, endocardial-specific expression; ET,
ectopic expression.